Abstracts

RCT OF A MULTISECTORAL AGRICULTURAL INTERVENTION TO IMPROVE HIV AND HEALTH OUTCOMES

Food insecurity and HIV viral suppression are linked through nutritional, mental health, and behavioral pathways. We examined the effects of a multisectoral agricultural intervention on HIV viral suppression, nutritional status, and mental health among people living with HIV (PLHIV) taking antiretroviral therapy (ART) in Kenya. For the Shamba Maisha cluster RCT (NCT02815579) we randomly allocated…

VIRAL LOAD MONITORING IN PUBLIC SECTOR CLINICS IN RURAL SOUTH AFRICA

Data from the public antiretroviral treatment (ART) register (TIER.Net) showed only a third of patients starting ART had viral load measured after 12 months. It is unclear how information from TIER.Net correlates with the true viral load monitoring (VLM) that patients receive and performance of the ART programme. We examined the clinical records of HIV-positive…

GENERIC DARUNAVIR AND DOLUTEGRAVIR ARE COST-EFFECTIVE IN SECOND-LINE ART

There will be greater need for second-line (2L) antiretroviral treatment (ART) as HIV treatment programs mature. Historically, most 2L regimens in resource-limited settings contained a ritonavir-boosted protease inhibitor (PI), either lopinavir (LPV/r) or atazanavir (ATV/r). The best-in-class PI, ritonavir-boosted darunavir (DRV/r), is now available as a generic with a lower cost than LPV/r. This, together…

TRANSITIONING WOMEN TO PREFERRED TLD REGIMEN IS LAGGING IN SUB-SAHARAN AFRICA

Dolutegravir-based (DTG) regimens perform better than efavirenz-based regimens in maintaining viral suppression. In 2018, the World Health Organization recommended tenofovir disoproxil fumarate-lamivudine-dolutegravir (TLD) as the preferred first line regimen. While access was initially limited for women due to safety concerns in pregnancy, in 2019, DTG was shown to be safe in pregnancy and TLD became…